The Indian surgical robot Mizzo Endo 4000 may not be the work of local engineers at all. A rival company has accused the robot’s manufacturers of importing equipment from China under the guise of local production.
Author: Dzmitry Korsak
Dzmitry Korsak
Experienced journalist and editor with over 25 years in the field. His work focuses on medical technologies, social issues, and innovation. He values an evidence-based approach, thorough work with primary sources, and the ability to communicate complex topics in a clear and accessible way.
We see MedTech today as a structural pillar of healthcare: tests and analyzers, monitors and pumps, CT/MRI and ultrasound scans, implants and disposables, as well as software for monitoring. Europe spends nearly 1% of the EU’s GDP on it; this figure may look modest to some, but the effect is cumulative and systemic, implying further steady growth. The money goes into tools without which patient pathways often cannot even start.
The Nobel Prize in Physiology or Medicine this year has been awarded to Mary E. Brunkow (Institute for Systems Biology, Seattle), Frederick J. Ramsdell (Sonoma Biotherapeutics, San Francisco) and Shimon Sakaguchi (Osaka University) “for their discoveries concerning peripheral immune tolerance.” The 11 million Swedish kronor prize will be shared equally, and the award ceremony will traditionally take place on 10 December in Stockholm.
A large multicenter study in the United States found that using ambient AI scribes for clinical documentation lowers burnout and eases workload for clinicians. The system tested was Abridge, rolled out across six health systems. Results were published on October 2, 2025, in JAMA Network Open.
A multi-pathology AI “copilot” that analyzes chest/abdomen CTs. It detects, segments, and packages results for over 20 acute pathologies in parallel targeting emergency department. We asked the founder of xAID, Kirill Lopatin, to walk us through the system’s core workflow.
The European Commission has announced significant changes that may soon reshape MedTech regulation in Europe. The first step on this path is to gather proposals and views from manufacturers, clinicians, notified bodies, and patient organizations.
Theranostics in nuclear medicine is a modern, mainstream approach that unites cancer diagnosis and treatment into a single, integrated system. It not only enables precise identification of tumors and their metastases but also allows targeted radionuclide therapy. Today, these methods are increasingly being included in international treatment protocols and offer patients a real chance to extend their lives and improve quality of life.
When people talk about digital health, they usually mean Zoomers and Millennials. A Rock Health (2024) survey shows: 68% of Millennials and 60% of Zoomers used virtual healthcare over the past year. Against this backdrop, it’s easy to believe that the healthtech market is aimed only at the young.
About 52,500 U.S. Medicare beneficiaries use remote patient monitoring (RPM) services — primarily for hypertension, diabetes, and musculoskeletal conditions. In Medicare Advantage plans, remote monitoring uptake has surged 14-fold from 2019 to 2022.
Today, the scientific community is actively discussing an experimental mRNA-based cancer vaccine developed at the University of Florida. It’s important to emphasize: this is not a preventive vaccine like those used against COVID‑19.